US Stock MarketDetailed Quotes
ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)
- 0.070
- 0.0000.00%
Close Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.070Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.10052wk High0.00P/B0Float Cap0.05752wk Low--Dividend TTM0Shs Float0.210Historical High--Div YieldTTM0.00%Amplitude0.057Historical Low--Avg Price1Lot Size
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|
| Total revenue | 0 | 0 |
| Operating revenue | --0 | --0 |
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | -34.89%7.7M | 11.83M |
| Selling and administrative expenses | 4.03%5.58M | --5.36M |
| -General and administrative expense | 4.03%5.58M | --5.36M |
| Research and development costs | -67.16%2.12M | --6.47M |
| Operating profit | 34.89%-7.7M | -11.83M |
| Net non-operating interest income expense | -59.04%-821.37K | -516.45K |
| Non-operating interest expense | 59.04%821.37K | --516.45K |
| Other net income (expense) | 232.35%441.58K | -333.66K |
| Gain on sale of security | 168.36%228.1K | ---333.66K |
| Special income (charges) | --213.48K | --0 |
| -Less:Other special charges | ---213.48K | ---- |
| Income before tax | 36.26%-8.08M | -12.68M |
| Income tax | ||
| Net income | 36.26%-8.08M | -12.68M |
| Net income continuous Operations | 36.26%-8.08M | ---12.68M |
| Minority interest income | ||
| Net income attributable to the parent company | 36.26%-8.08M | -12.68M |
| Preferred stock dividends | ||
| Other preferred stock dividends | ||
| Net income attributable to common stockholders | 36.26%-8.08M | -12.68M |
| Basic earnings per share | ||
| Diluted earnings per share | ||
| Dividend per share | ||
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data